Snapshot Of Surgical Cancer Trial Recruitment at a Single Centre
• Surgical intervention is central to cancer management and makes the greatest contribution to cure, of
all available modalities.
• Despite such potential, surgical research has been highlighted by the National Cancer Research
Institute (NCRI) 2008–2013 Strategic Plan as being under threat.
• 1.8% of projects funded by NCRI partners explicitly focused on questions about the use of surgery.
• 2.8% of all funding for cancer related project/programme grants and personal awards was allocated to
• Retrospective review
• 20 patients discussed at the subspecialty multi-disciplinary team meetings (Colorectal, Upper
Gastrointestinal, Breast, Urology and Gynaecology)
• May 2017
• Somerset Registry entry, clinic letters and electronic case-notes were reviewed.
• UK Clinical Trials Gateway was examined to determine if the patient had been suitable for an actively
To assess whether surgical cancer patients at a single centreare being considered for and offered entry into a surgical trial.
Only 1 patient was offered entry into a clinical trial. 26 patients would have been eligible for entry into a clinical trial.
The poor trial recruitment identified across all subspecialties could be improved by; increasing clinicians’ awareness of active trials, including a reminder to consider trials on the MDT proforma, funding dedicated research clinics and by encouraging trainee involvement.